Irreversible electroporation in renal tumours: a systematic review of safety and early oncological outcomes

Hilton, A., Kourounis, G. and Georgiades, F. (2022) Irreversible electroporation in renal tumours: a systematic review of safety and early oncological outcomes. Urologia Journal, 89(3), pp. 329-337. (doi: 10.1177/03915603221077590) (PMID:35139717) (PMCID:PMC9310143)

[img] Text
265631.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

853kB

Abstract

We review the safety and early oncological outcomes of irreversible electroporation (IRE), a novel non-thermal ablation technique, in small renal masses (SRMs). Following PROSPERO registration (CRD42020197943), a systematic search of MEDLINE, EMBASE and SCOPUS databases according to PRISMA guidelines was performed. Critical appraisal of the included studies was performed using the Newcastle-Ottawa Scale. Of 224 articles screened, 10 met the inclusion criteria. In total, 83 patients were identified. Except for one cohort study (n = 41), the remaining studies were case series of n < 10. Follow up was <12 months in 7/10 articles (range 3–34 months). About 10/10 articles reported safety outcomes. There were no 30-day mortalities. The most frequently reported adverse events were transient haematuria (11/83) and asymptomatic perirenal haematomas (7/83). About 62/63 patients with reported length of stay were discharged within 24 h. No significant long-term changes in renal function were reported. About 7/10 articles reported oncological outcomes. Only one article assessed histopathological outcomes, whilst the remaining studies used cross-sectional imaging modalities to assess efficacy, recurrence or disease progression. About 4/7 patients with histopathology outcomes, showed complete response (CR). About 43/55 patients with radiological outcomes showed CR. No mortalities were reported due to SRMs. These initial findings support IRE as safe and feasible in managing SRMs. However, results from larger studies with longer follow-up are needed to evaluate oncological outcomes and compare these with other ablation methods.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kourounis, Dr Georgios
Authors: Hilton, A., Kourounis, G., and Georgiades, F.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Urologia Journal
Publisher:SAGE Publications
ISSN:0391-5603
ISSN (Online):1724-6075
Published Online:10 February 2022
Copyright Holders:Copyright © 2022 The Author(s)
First Published:First published in Urologia Journal 89(3): 329-337
Publisher Policy:Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record